ImmunityBio (IBRX) Assets Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.49% |
| Dec 31, 2025 | 11.47% |
| Sep 30, 2025 | 13.71% |
| Jun 30, 2025 | 8.17% |
| Mar 31, 2025 | -7.96% |
| Dec 31, 2024 | -6.53% |
| Sep 30, 2024 | 19.35% |
| Jun 30, 2024 | 21.73% |
| Mar 31, 2024 | 24.14% |
| Dec 31, 2023 | 31.59% |
| Sep 30, 2023 | 33.80% |
| Jun 30, 2023 | 14.08% |
| Mar 31, 2023 | 39.31% |
| Dec 31, 2022 | 36.29% |
| Sep 30, 2022 | 30.12% |
| Jun 30, 2022 | 21.83% |
| Mar 31, 2022 | 23.22% |
| Dec 31, 2021 | 37.10% |
| Sep 30, 2021 | 2.07% |
| Jun 30, 2021 | 5.22% |
| Mar 31, 2021 | -3.05% |
| Dec 31, 2020 | -4.03% |
| Sep 30, 2020 | -13.38% |
| Jun 30, 2020 | -13.36% |
| Mar 31, 2020 | -25.21% |
| Dec 31, 2019 | -23.32% |
| Sep 30, 2019 | -21.60% |
| Jun 30, 2019 | -19.98% |
| Mar 31, 2019 | -16.48% |
| Dec 31, 2018 | -20.84% |
| Sep 30, 2018 | -18.53% |
| Jun 30, 2018 | 16.84% |
| Dec 31, 2017 | 61.01% |